Indications
Zynrelef is indicated for treatment of somatic postoperative pain from small- to medium-sized surgical wounds in adults (see section 5.1).
Composition
- Active substance
- bupivacaine, meloxicam
- International name (INN)
- bupivacaine;meloxicam
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zynrelef
- Active substance
- bupivacaine, meloxicam
- ATC code
- N01B
- Group
- Nervous system
- Therapeutic area
- Pain, Postoperative
- Marketing authorisation holder
- Heron Therapeutics, B.V.
- Status
- Withdrawn